AUPH compared with NNDM: revenue, margins and what each company keeps, and the suppliers and customers both name

AUPHAurinia Pharmaceuticals Inc.

Mkt capRevenueRevenue

NNDMNano Dimension Ltd.

Mkt capRevenueRevenue

Compare

AUPHAurinia Pharmaceuticals Inc.

NNDMNano Dimension Ltd.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AUPH

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±8.3%▼−3.25%×0.40

Q2 FY26±10.2%▲+6.19%×0.61

May 7 '26±7.5%▼−6.80%×0.91

Q1 FY26±10.8%▼−3.19%×0.30

NNDM

No earnings history for NNDM.

= impliedAUPH realized, solidNNDM realized, hatchedOne scale, both sides: full bar = 11%× = |realized| ÷ impliedSource: market data

AUPHAurinia Pharmaceuticals Inc.

16.66▼−3.20%· post 16.94

Mkt cap$2.2BRevenue$84MQ3 FY26Revenue$283MFY25

NNDMNano Dimension Ltd.

1.35▼−3.17%· post 1.35

ClosedOct 30 '26

Mkt cap$280.4MRevenue$29MQ2 FY26Revenue—

Compare

ClosedOct 30 '26

AUPHAurinia Pharmaceuticals Inc.

NNDMNano Dimension Ltd.

16.66▼−3.20%post 16.94

Price

1.35▼−3.17%post 1.35

$2.2B

Mkt cap

$280.4M

Q3 FY26$84M

Revenue

$29MQ2 FY26

FY25$283M

Revenue

—

AUPH16.66▼−3.20%vsNNDM1.35▼−3.17%ClosedOct 30 '26